Fig. 2From: Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitorsStructure of antibacterial active compounds comprising benzothiazole scaffoldBack to article page
